Breast Cancer Profiling Project, Drug Sensitivity phase I: Fixed-cell GR measures of 35 breast cell lines to 34 small molecule perturbagens from library plate I. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20343)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Primary Target Pathway Mean Normalized Growth Rate Inhibition Value Increased Fraction Dead
HCC1428 Cediranib
0.0031623
VEGFR/cKIT
RTK
 1.0052 -0.00342
HCC1428 Cediranib
0.01
VEGFR/cKIT
RTK
 1.0350 -0.00540
HCC1428 Cediranib
0.031623
VEGFR/cKIT
RTK
 0.9364 -0.00305
HCC1428 Cediranib
0.1
VEGFR/cKIT
RTK
 0.9429 -0.00293
HCC1428 Cediranib
0.31623
VEGFR/cKIT
RTK
 0.9279 0.00033
HCC1428 Cediranib
1.0
VEGFR/cKIT
RTK
 0.7957 0.00284
HCC1428 Cediranib
3.1623
VEGFR/cKIT
RTK
 0.5526 0.04094
HCC1428 Cediranib
10.0
VEGFR/cKIT
RTK
 -0.5502 0.53304
HCC1428 Cabozantinib
0.001
VEGFR2/MET
RTK
 1.0383 -0.00446
HCC1428 Cabozantinib
0.0031623
VEGFR2/MET
RTK
 1.0360 -0.00390
HCC1428 Cabozantinib
0.01
VEGFR2/MET
RTK
 1.0784 -0.00314
HCC1428 Cabozantinib
0.031623
VEGFR2/MET
RTK
 1.0983 -0.00483
HCC1428 Cabozantinib
0.1
VEGFR2/MET
RTK
 0.9806 -0.00580
HCC1428 Cabozantinib
0.31623
VEGFR2/MET
RTK
 1.0072 -0.00615
HCC1428 Cabozantinib
1.0
VEGFR2/MET
RTK
 0.9940 0.00009
HCC1428 Cabozantinib
3.1623
VEGFR2/MET
RTK
 0.8842 -0.00155
HCC1428 Cabozantinib
10.0
VEGFR2/MET
RTK
 0.6310 0.02239
HME1 Abemaciclib
0.001
CDK4/6
Cell cycle
 1.0652 0.00103
HME1 Abemaciclib
0.0031623
CDK4/6
Cell cycle
 0.9991 -0.00594
HME1 Abemaciclib
0.01
CDK4/6
Cell cycle
 0.8808 -0.00310
HME1 Abemaciclib
0.031623
CDK4/6
Cell cycle
 0.7233 0.00199
HME1 Abemaciclib
0.1
CDK4/6
Cell cycle
 0.5801 0.00750
HME1 Abemaciclib
0.31623
CDK4/6
Cell cycle
 0.4360 0.00857
HME1 Abemaciclib
1.0
CDK4/6
Cell cycle
 0.2792 0.03205
HME1 Abemaciclib
3.1623
CDK4/6
Cell cycle
 0.1407 0.04004